The QualityStocks Daily Stock List
- Cannabis Suisse Corp. (CSUI)
- Tapinator, Inc. (TAPM)
- AmeriCann, Inc. (ACAN)
- BioCorRx, Inc. (BICX)
- H-Cell Energy Corporation (HCCC)
- Minerco, Inc. (MINE)
- Reflect Scientific, Inc. (RSCF)
- Applied Biosciences Corp. (APPB)
- EOS, Inc. (EOSS)
- Nautilus Minerals, Inc. (NUSMF)
- International Frontier Resources Corporation (IFRTF)
- AEON Global Health Corp. (AGHC)
- CareView Communications, Inc. (CRVW)
- Oncolix, Inc. (ONCX)
Cannabis Suisse Corp. (CSUI)
OTC Markets, Street Insider, Investors Hangout, Simply Wall St, Market Screener, Stockhouse, Stockwatch, wallstreet: online, Dividend Investor, and GlobeNewswire reported earlier on Cannabis Suisse Corp. (CSUI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Cannabis Suisse Corp. operates as a licensed cannabis cultivation and distribution enterprise for recreational tobacco products and medical CBD (cannabidiol) oils in Switzerland. It is a research & development (R&D) organization licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. Its main activities in producing cannabis are based in Zurich, Switzerland. The Company grows high quality, organic cannabis with sustainable, all-natural principles. In August of 2018, Forbes magazine listed Switzerland as the third most overlooked marijuana market worldwide.
The Company was previously known as Geant Corp. It changed its name to Cannabis Suisse Corp. in February of this year. Established in 2016, Cannabis Suisse has its head office in Dietikon, Switzerland.
The Company operates in Europe and pursues new and developing cannabis markets where possible via its own network of wholesale distributors, its e-commerce and mobile applications, brick and mortar retail stores, and grocery store retailers.
Cannabis Suisse provides high CBD tobacco substitutes made from the well-known strains with low THC (tetrahydrocannabinol) and high CBD. The Company extracts CO2 for its own production and for manufacturers/farmers in Switzerland. It clones its own mother plants. As a result, it ensures the quality and taste will be consistent each time customers use its products.
Cannabis Suisse produces chocolate beans, e-cigarette oil, and also tea products with high CBD percentage. Its cannabis is stored in a cool, dark location for optimal results. The ideal storage temperature for the finished dried cannabis product is 2 °C to 6 °C with a shelf-life of 12 months.
The Company has entered into a partnership with Royal Danish Cigars Ltd. This partnership is to develop a luxury product line of cannabis and tobacco blended cigars, marketed under the label SwissCigars™. SwissCigars™ will produce 1 percent THC versions for local consumption and 0.2 percent THC cigars legal for export. These cannabis cigars will be hand rolled in Switzerland by Cuban master rollers. They will subsequently be decorated with 24 KT Swiss Gold and Swarovski.
Cannabis Suisse has strategic investments and Swiss partnerships. With these the Company provides a broad array of first-rate quality cannabis and hemp products, develops unique technologies, promotes cannabis consumer health and wellness, and delivers a premier customer experience with its brand CannaMec™.
This week, Cannabis Suisse announced the launching of a new product in its retail brand Alpine Cannabis. Alpine Cannabis CBD Pure Base is an e-liquid for electronic cigarettes. It’s a boost of CBD to any e-liquids. It comes with different levels of CBD strengths.
Alpine Cannabis CBD Pure Base provides Certified CBD concentration in a 10 mL bottle. It is guaranteed without THC and is nicotine free. It contains no alcohol, and no animal extracts and has USP/Food Grade ingredients. The products is tamper-proof and child-proof and diacetyl free and quality controlled.
Cannabis Suisse Corp. (CSUI), closed Friday's trading session at $1.13, even for the day, on 91210 volume. The average volume for the last 3 months is 1,001 and the stock's 52-week low/high is $2.00/$2.70000004.
Tapinator, Inc. (TAPM)
NetworkNewsWire, Zacks, TipRanks, Market Screener, Simply Wall Street, 4-Traders, Stockopedia, TradingView, Stockhouse, InvestorsHub, Wallet Investor, and TMX Money reported beforehand on Tapinator, Inc. (TAPM), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Tapinator, Inc. is a developer and publisher of category leading applications (apps) for mobile platforms. The Company develops and publishes mobile games and apps on the iOS, Google Play, and Amazon platforms in North America, Europe, and Asia. Its library includes more than 300 titles that, collectively, have realized greater than 450 million mobile downloads. This includes noteworthy properties such as Video Poker Classic, Solitaire Dash, as well as Crypto Trillionaire. Established in 2013, Tapinator is based in New York, New York. The Company has product development and marketing teams located in North America, Europe, and Asia.
Tapinator generates revenues via the sale of branded advertising and through consumer transactions. This includes in-app purchases and subscriptions.
Tapinator previously announced the January 31, 2019 worldwide release of Crypto Trillionaire exclusively on Apple's iOS platform. The Company joined forces with the game's developer, Robot Cake Games of Hannover, Germany, to bring the innovative, best-in-class idle tapper game to mobile players around the world. Subsequent to its initial international launch on iOS, Crypto Trillionaire was featured by Apple as a "New Game We Love," in 152 countries, including the United States. Crypto Trillionaire is the first of a number of planned major releases for Tapinator's category-leading Games & Apps business for this year.
Tapinator announced this past April that it launched a major update to Video Poker Classic, the leading video poker game on mobile. The Company’s new 2.0 version brings multi-hand capability, a popular casino feature, to the game's core single-hand gameplay.
Tapinator introduced Triple Play, Five Play, and Ten Play for all of its 39 game types. With the new version, Video Poker Classic has the richest offering of any video poker title on mobile devices, in terms of game types, gameplay formats (Single Hand, Triple Play, Five play, Ten play) and overall functionality.
Moreover, Tapinator is developing a new social casino game. The unique mobile title is scheduled for launch in Q4 of this year. The upcoming game features a slot mechanic, with inventive metagame systems, which have proven their success in the world of real money gaming. The title is made possible via the Company's recent licensing deal with a major European real-money slots developer.
The real-money version of the product is now a top performing slot game across more than 200 online casinos in several European nations. Tapinator will be announcing the details of the partnership closer to the game's launch.
Tapinator, Inc. (TAPM), closed Friday's trading session at $0.0554, off by 9.772%, on 85,256 volume with 7 trades. The average volume for the last 3 months is 64,855 and the stock's 52-week low/high is $0.481000006/$1.72000002.
AmeriCann, Inc. (ACAN)
NetworkNewsWire, Daily Marijuana Observer, OTC Markets, Trading View, Profit Confidential, TipRanks, Insider Financial, Equities, Stockhouse, Market Screener, Financial Buzz, InvestorsHub, and Wallet Investor reported beforehand on AmeriCann, Inc. (ACAN), and today we report on the Company, here at the QualityStocks Daily Newsletter.
AmeriCann, Inc. designs, develops, and owns medical cannabis facilities to produce medical cannabis in the United States. The Company partners with local businesses to serve marijuana patients in their communities. It is developing state-of-the-art cultivation, processing, and also product manufacturing facilities. It uses greenhouse technology for cannabis cultivation and is designing GMP Certified cannabis extraction and product manufacturing infrastructure. OTCQB-listed, AmeriCann is based in Denver, Colorado.
Essentially, the Company’s goal is to serve cannabis patients and consumers through providing state-of-the-art facilities designed and built to produce high quality, consistent cannabis cultivated and processed in a controlled, secure, and sustainable environment. In addition, regarding its Real Estate Services, AmeriCann utilizes a proven strategy for identifying, acquiring and developing real estate specifically suited for cannabis operations. Moreover, concerning Licensing Procurement, AmeriCann has been contributory in winning cannabis licenses in competitive application processes across the nation.
The Company, via a wholly-owned subsidiary, AmeriCann Brands, Inc., intends to secure licenses to cultivate cannabis and produce cannabis infused products. This includes beverages, edibles, topicals, vape cartridges, and concentrates. AmeriCann Brands, Inc. plans to operate a Marijuana Product Manufacturing business at the Massachusetts Cannabis Center with greater than 40,000 square feet of state-of-the art extraction and product manufacturing infrastructure.
AmeriCann has its flagship project, the Massachusetts Cannabis Center (MCC). The MCC is undergoing development on a 52-acre parcel in Southeastern Massachusetts. The MCC project is permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure for the existing medical cannabis and the newly developing adult-use cannabis marketplace. Building 1 of the MCC is a 30,000 square foot cultivation and processing facility.
AmeriCann has a 15-year Joint Venture Partnership with Bask, Inc. Bask is an existing Massachusetts licensed vertically integrated cannabis operator. AmeriCann will receive a Revenue Participation Fee of 15 percent of Gross Revenue on all products produced and sold from Building 1.
This month, AmeriCann provided a construction update on Building 1 of its Massachusetts Cannabis Center (MCC). The construction of Building 1 of the MCC is 90 percent complete. The project recently received a Temporary Certificate of Occupancy. This means the building is approved for staff to start moving in equipment and fixtures in preparation for final inspections. AmeriCann expects to receive a final Certificate of Occupancy for Building 1 later this summer.
This week, AmeriCann commented on the hearing on the SAFE Banking Act and the positive outlook for federal cannabis legislation. Sponsored by a bi-partisan group of 31 Senators, the SAFE Banking Act would give cannabis businesses, operating in States where cannabis is legal, access to banking and financial services. In addition, it would protect banks that offer these services to regulated cannabis businesses.
AmeriCann Chief Executive Officer, Mr. Tim Keogh, said, “After decades of advocacy and cannabis policy development, we are experiencing overwhelming public support for medical and adult-access cannabis in the U.S. Making it possible for cannabis businesses to access capital and other banking services like all other legal businesses would clear the way for greater innovation and growth in the industry.”
AmeriCann, Inc. (ACAN), closed Friday's trading session at $1.10, up 2.8037%, on 10,732 volume with 27 trades. The average volume for the last 3 months is 38,857 and the stock's 52-week low/high is $1.42999994/$4.50.
BioCorRx, Inc. (BICX)
NetworkNewsWire, Zacks, Uptick Newswire, Stockwatch, Proactive Investors, Wallet Investor, The Street, InvestorsHub, Stockhouse, MarketBeat, Stockopedia, and Equity Clock reported previously on BioCorRx, Inc. (BICX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
BioCorRx, Inc. is a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders. The Company provides an innovative approach to the treatment of substance abuse addiction and related disorders. The BioCorRx® Recovery Program is its non-addictive, medication-assisted treatment (MAT) program. OTCQB-listed, BioCorRx has its corporate office in Anaheim, California. The Company also conducts R&D under its controlled subsidiary, BioCorRx Pharmaceuticals.
BioCorRx is a healthcare solutions enterprise. The Company is at the frontline of alcohol and opioid addiction treatment. Its commitment is to improving the quality of life for recovering addicts. BioCorRx’s recovery program is an outpatient MAT program for alcohol and opioid drug addiction. The BioCorRx® Recovery Program is used by a network of independently owned and operated treatment centers located throughout the United States.
The BioCorRx® Recovery Program consists of two chief components. The first component consists of an outpatient implant procedure performed by a licensed physician. This implant delivers the non-addictive medicine, naltrexone, an opioid antagonist, which can substantially decrease physical cravings for alcohol and opioids. In addition, Naltrexone can prevent opioid overdose following relapse.
The second component of the program is a Cognitive Behavioral Therapy (CBT) program. It is tailored expressly for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment.
This past May, BioCorRx announced that it unveiled its new UnCraveRx™ Weight Loss Program. UnCraveRx™ is a novel weight loss program. It combines medically assisted weight loss management with lifestyle behavioral support. The goal of the UnCraveRx™ specialized weight loss program is to help participants attain healthy, sustainable weight goals. UnCraveRx™ will combine a naltrexone pellet insertion procedure performed by a licensed medical professional.
This week, BioCorRx announced that it launched the UnCraveRx™ virtual application (app). UnCraveRx™ helps to lessen food cravings combined with on-demand virtual lifestyle support, fitness and nutrition. The estimated launch of the full UnCraveRx™ program is October 2019. However, the UnCraveRx™ app is available now. It is available online at www.myuncraverx.com or via the Android or iOS app stores.
Lourdes Felix, CFO, COO and Director, stated, “The UnCraveRx™ app fits people of all ages and stages of life, and provides a personalized experience that can help to eliminate many time barriers for meal planning and regular physical activity.”
BioCorRx, Inc. (BICX), closed Friday's trading session at $3.90, up 1.0363%, on 362 volume with 5 trades. The average volume for the last 3 months is 1,515 and the stock's 52-week low/high is $0.50/$5.00.
H/Cell Energy Corporation (HCCC)
Financial Buzz, OTC Markets, Street Insider, Morningstar 4-Traders, Stockwatch, Uptick Newswire, Marketbeat, Market Screener, Simply Wall St, Stockhouse, and Wallet Investor reported previously on H/Cell Energy Corporation (HCCC), and we also report on the Company, here at the QualityStocks Daily Newsletter.
H/Cell Energy Corporation designs and implements clean energy solutions featuring hydrogen and fuel cell technology. The Company is an integrator that centers on the design and implementation of clean energy solutions. This includes solar, battery, fuel cell and hydrogen generation systems. By way of its subsidiaries, it also provides environmental systems and security systems integration. OTCQB-listed, H/Cell Energy is based in Dallas, Texas.
H/Cell serves the residential, commercial, as well as government sectors. It has developed and implemented a hydrogen energy system used to completely power a residence or commercial property with clean energy. This is so it can run independent of the utility grid and also provide energy to the utility grid for monetary credits. This inventive system utilizes renewable energy as its source for hydrogen production.
The HC-1 system is totally scalable. Upon installation, the HC-1 system operates as a self-sustaining energy system providing electricity and/or hydrogen fuel for transportation.
The design of the HC-1 system is to provide clean energy for a better environment. The system eliminates the electric bill and dependence on fossil fuels. Furthermore, this system allows one to benefit with tax and energy credits while helping make the environment safe for future generations. H/Cell Energy’s completed systems include the De Tiberge Property in Pennington, New Jersey and the Strizki Property in Hopewell, New Jersey.
This month, H/Cell Energy announced that it entered into an equity purchase agreement with GHS Investments LLC (GHS). This agreement will provide the Company access to capital over a 24 month period.
Mr. Andrew Hidalgo, H/Cell Energy Chief Executive Officer, said, "We are very pleased to come to terms with GHS. We have reviewed many proposals for equity investments over the last year, most of which were unsuitable. However, we found GHS to be professional, competent and flexible in constructing an equity investment arrangement that we believe is beneficial to our shareholders. We intend to use any proceeds for growth initiatives as we continue to focus on building shareholder value.”
H/Cell Energy Corporation (HCCC), closed Friday's trading session at $0.6227, even for the day, on 1,000 volume. The average volume for the last 3 months is 163 and the stock's 52-week low/high is $0.035199999/$0.507000029.
Minerco, Inc. (MINE)
TipRanks, Investing.com, Streetwise Reports, Global Banking and Finance, Market Wire News, Metals News, Wallet Investor, Dividend Investor, Infront Analytics, TradingView, Nasdaq, Market Screener, GlobeNewswire, PR Newswire, InvestorsHub, Stockwatch, Stockopedia, Investors Hangout, and Stockhouse reported earlier on Minerco, Inc. (MINE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Minerco, Inc. is a brand management business specializing in the development of beverage, entertainment, and also ancillary brands. The present Minerco beverage brand umbrella includes VitaminFIZZ® and The Herbal Collection™. The Company was previously known as Minerco Resources, Inc. It changed its name to Minerco, Inc. in October of 2015. Its shares trade on the OTC Markets. Minerco has its corporate headquarters in Katy, Texas.
Minerco’s entertainment company is Fuse Live Events. It supplements the Company’s portfolio via the generation, production, and promotion of premier quality live entertainment. These include concerts, festivals as well as other live events.
Minerco’s new management is concentrating on entertainment and media assets. This is in addition to enhancing the Company’s proprietary beverage formulas with added functionality, to include CBD (cannabidiol).
Last month, Minerco and Anything Technologies Media, Inc. (EXMT) announced that the companies signed a joint venture (JV) agreement to develop, market, and distribute a new line of CBD products. The JV will take advantage of Minerco’s proven beverage formulations and distribution with Anything Technologies Media’s (ATM’s) hemp/CBD expertise to jointly and efficiently take the new line of products to the marketplace. ATM is a manufacturer and developer of CBD products.
The initial product to undergo development and launching will be a zero calorie, vitamin packed CBD water. Upon initial CBD water development being complete, the JV’s plan is to quickly add coffee-based CBD and other products to the portfolio.
Mr. Milton Murcia, Minerco’s Chief Executive Officer, said, "We are very pleased to have partnered with ATM in this joint venture. The combined yet specialized expertise of both companies is exactly what we have been looking for. Both companies have the vision, resources and knowledge to create superior CBD products that will benefit the millions of people who want and need them. This is just the start to our vision of being a leader in the development and distribution of health conscience CBD products.”
Minerco, Inc. (MINE), closed Friday's trading session at $0.0002, even for the day, on 20,958,413 volume with 21 trades. The average volume for the last 3 months is 34,579,289 and the stock's 52-week low/high is $0.05/$0.319999992.
Reflect Scientific, Inc. (RSCF)
StockPulse, All Stocks Today, PennyStockBase, StocksNewsFeed, Financial Buzz, Street Insider, Stockwatch, Last10k, Market Screener, and GlobeNewswire reported earlier on Reflect Scientific, Inc. (RSCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Reflect Scientific, Inc. provides varied products and services for diverse industries. The Company has products that range from testing applications for harmful chemicals to energy efficient cryogenic freezers. Reflect’s customers include hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, universities, government and private sector research facilities, and chemical and industrial companies. Reflect Scientific is headquartered in Orem, Utah.
Essentially, the Company develops and markets unique, proprietary, and patented technologies in blast freezing, storage cooling, and thawing. Its product line up includes Cryometrix, Visacon, LCGCVials.com, GCFerrules.com, and HPLCDeterctors.com.
Cryometrix blast freezing, storage cooling, and thawing products use a pioneering liquid nitrogen technology. This technology doesn't require a compressor or CFCs. It has low energy usage and considerably decreased maintenance. Visacon provides premier quality OEM (original equipment manufacturer) products for chromatography from laboratory consumables to UV/VIS instrumentation.
LCGCVials.com manufactures vials. It sells them direct to consumer. GCFerrules.com has supplied OEM GC consumable products for greater than two decades. HPLCDeterctors.com provides a range of premier UV Detectors. This is from variable wavelength analytical units to fixed wavelength compact detectors to integrate in an instrument or utilize as a standalone unit.
This week, Reflect Scientific announced an update from Chief Executive Officer, Mr. Kim Boyce. Mr. Boyce noted that in 2018, the Company’s sales grew 45 percent because of increased sales of its Cryometrix Liquid Nitrogen Technology powered freezers for the Bio/Pharma sector. He said that all of Reflect’s freezers are manufactured in Utah, and numerous efficiencies have been initiated that will lessen the Company’s annual operating costs by $151,000.
At present, Reflect Scientific has 15 approved patents, with 11 pending patents, having filed 7 patents within the past 18 months. Recently, the Company received an award from the State of Utah for introducing green technology for replacing the diesel driven compressor systems for controlling the temperature of Reefer trucks – mainly used for the transportation of produce.
Mr. Boyce also noted that Cold Chain Management in general is a real opportunity for Reflect in terms of providing a complete range of products, which address Storage, Processing, and Shipment. He also said that another market opportunity has also recently emerged for Reflect – the Cannabis Industry.
The Company just completed the production and sale of a cryogenic system for Cannabis (CBD) processing. Moreover, it has been approached to make additional units. Reflect’s state-of-the-art CBD (Liquid Nitrogen) chilling systems improve efficiencies of processing companies by up to 10 times what their present equipment accomplishes.
Reflect Scientific, Inc. (RSCF), closed Friday's trading session at $0.05, even for the day, on 62,000 volume. The average volume for the last 3 months is 7,984 and the stock's 52-week low/high is $0.035100001/$0.100000001.
Applied Biosciences Corp. (APPB)
InvestorsHub, MarketWatch, Wallet Investor, Uptick Newswire, GuruFocus, Investors Hangout, Dividend Investor, Daily Marijuana Observer, Talk Markets, Corporate Information, Barchart, Trading View, Accesswire, Small Cap Podcast, The Street, and Stockhouse reported earlier on Applied Biosciences Corp. (APPB), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Applied Biosciences Corp. is a diversified cannabinoid therapeutics company. Its focus is on the medical, bioceutical, testing and pet health industries. The Company’s emphasis is on select investment, consumer brands, and partnership opportunities in the medical, health and wellness, nutraceutical, and pet industries. Applied Biosciences has its corporate office in Beverly Hills, California.
Applied Biosciences is a leading company in the CBD and Pet health space. It is currently shipping to the majority of U.S. States and also to numerous international countries. The Company has a number of strategic partnerships now in place. It is pursuing additional partnerships and other strategic growth opportunities.
Applied Biosciences’ products include Remedi and Herbal Pet. The team at Remedi, based in Colorado, is a collaboration project of hemp and CBD industry professionals. Remedi has launched an initial line of hemp CBD infused products centered on delivery methods with proven and noticeable effects.
Herbal Pet’s focus is a new standard of care in pet health. Its product can provide safe, natural, veterinarian-recommended products directly to owners. Herbal Pet delivers premier quality cannabinoid-based nutraceuticals for cats and dogs.
Recently, Applied Biosciences announced it signed a partnership agreement with Shannon “the Cannon” Briggs, the former heavyweight boxing champion and world record-holder for the most first round knockouts. Via this new partnership, Shannon Briggs and Applied Biosciences will work together to formulate a line of athlete-focused cannabidiol (CBD) based health and wellness supplements to enhance training and recovery under the “Champ Organics” brand.
Applied Biosciences also recently announced it retained the Emmes Group to assist with the development and execution of the Company's partnership and technology licensing initiatives and strategies. By way of the new partnership, Emmes and Applied Biosciences will work together to formulate a line of medical and scientific focused cannabidiol (CBD) based products to target the endocannabinoid system under the "Applied BioPharma" brand.
Applied Biosciences Corp. (APPB), closed Friday's trading session at $0.797, up 44.9091%, on 200 volume with 1 trade. The average volume for the last 3 months is 1,896 and the stock's 52-week low/high is $0.0019/$0.025499999.
EOS, Inc. (EOSS)
OTC Markets, Barchart, Stockhouse, InvestorsHub, 4-Traders, The Street, Wolf Street, Dividend Investor, Seeking Alpha, Morningstar, MarketWatch, last10k, Stockopedia, Wallet Investor, Real Investment Advice, and Trading View reported earlier on EOS, Inc. (EOSS), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
EOS, Inc. has a broad distribution network of associates with many dealer companies providing health care, beauty care, and environmentally friendly cleaning products in Asia. Since Q1 of 2017, the Company has expanded its marketing channels in China and Southeast Asian countries. Formed in 2015 and OTCQB-listed, EOS is headquartered in Taipei, Taiwan.
The Company previously acquired all of the issued and outstanding shares of Emperor Star International Trade Co. Ltd. (effective May 3, 2017). This is the trading team that plays a vital part in the supply chain of EOS products. EOS acquired Emperor Star trading company in Taipei, Taiwan to strengthen its business and prepare for the challenge of OBOR (One Belt and One Road) development in Malaysia, Indonesia, Thailand, and Cambodia. Emperor Star has been distributing highly unique health and beauty care products and environmentally friendly cleaning products, with first-rate growth in China and Asia.
EOS focuses on the marketing and distribution of skin care products to resellers in Taiwan. It engages in the distribution and marketing of skin care products manufactured by A.C. (USA), Inc. Its products include moisturizers, serums, cleansers, and toners. Products also include exfoliators, acne and oil correctors, facial masks, cleansing devices, and sun care products.
In 2017, Mr. Ben Yang, the chief representative of Asian market, EOS, Inc., signed agency contracts in Nanning City, Guangxi, China, with three owners of new flagship stores launched there. There are four flagship stores set up in China. This includes the first one in Quanzhou. This will help contribute to growing the business of EOS in China. Nanning City is the largest economy of Guangxi province.
On November 30, 2018, EOS signed a contract with A-Best Company and commenced to march toward the worldwide 3C market. A-Best Company is a foremost manufacturer of advanced Piezoelectric Ceramic Speakers.
The collaboration contract was signed by Mr. Yang He-Hsiang, President of EOS, and Mr. Lai Ying-Min, President of A-Best Wire Harness & Components Co., Ltd., at Gloria Prince Hotel in Taipei, Taiwan. The focus of this collaboration is on promoting A-Best Company's patented products, Piezoelectric Ceramic Speakers, and developing more value added products to the international 3C market.
EOS, Inc. (EOSS), closed Friday's trading session at $1.89, up 26.8456%, on 1,219 volume with 12 trades. The average volume for the last 3 months is 242 and the stock's 52-week low/high is $0.090000003/$0.495999991.
Nautilus Minerals, Inc. (NUSMF)
OTC Markets, PennyStockTweets, Stockhouse, Equities, Marketwired, InvestorsHub, Barchart, Junior Mining Network, The Street, MarketWatch, and YCharts reported previously on Nautilus Minerals, Inc. (NUSMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Nautilus Minerals, Inc. is the first company to explore the ocean floor for polymetallic Seafloor Massive Sulphide (SMS) deposits. Nautilus is developing a production system utilizing existing technologies adapted from the offshore oil and gas industry, dredging and mining industries to enable the extraction of these high-grade SMS systems on a commercial scale.
Nautilus Minerals has offices in Brisbane, Australia; Canada; and in Kavieng, New Ireland, Papua New Guinea, and Nuku'alofa, Tonga, South Pacific.
A seafloor resource exploration business, Nautilus explores and develops the ocean floor for copper, gold, silver, and zinc SMS deposits. Furthermore, the Company explores for manganese, nickel, copper, and cobalt nodule deposits. Nautilus has its copper-gold project named Solwara 1. It is under development in the territorial waters of Papua New Guinea (PNG).
The Solwara 1 deposit sits on the seafloor at a water depth of about 1600 meters. Solwara 1 contains a copper grade of approximately 7 percent. This compares with land-based copper mines, where the copper grade today averages 0.6 percent.
Gold grades of substantially more than 20 g/tonne have been recorded in some intercepts at Solwara 1. The average grade is roughly 6 g/tonne. Moreover, the Company holds highly prospective exploration acreage in the western Pacific (granted and under application), and in international waters in the Central Pacific.
Nautilus Minerals is currently negotiating the terms of an agreement with arm's length third parties. This would involve the establishment of a new joint venture company (the Vessel JV) to be owned by the third parties and Nautilus’ subsidiary, Nautilus Minerals Niugini Limited (NMN).
The purpose of the Vessel JV would be to fund the acquisition of the Production Support Vessel (PSV) that Nautilus had previously arranged to be obtained through MAC Goliath Pte Ltd (MAC) and the integration expenses of installing the mining equipment on the PSV. The Vessel JV would own and operate the fully integrated PSV.
Recently, Nautilus Minerals announced that it and Deep Sea Mining Finance Ltd. agreed to extend the maturity date of the existing secured loan facility that is currently due on February 8, 2019, for 28 days ending on March 8, 2019.
Nautilus continues to seek short and long term funding solutions. This is while assessing its options, including different restructuring options. Negotiations with various third parties continue.
Nautilus Minerals, Inc. (NUSMF), closed Friday's trading session at $0.02, up 100.00%, on 2,000 volume with 1 trade. The average volume for the last 3 months is 36,065 and the stock's 52-week low/high is $0.011199999/$0.264999985.
International Frontier Resources Corporation (IFRTF)
Connecting Investor, YCharts, Wallet Investor, GuruFocus, 4-Traders, MarketWatch, Stockhouse, Marketwired, Otc.Watch, Investment Pitch, Investors Hub, Investing News, Market Screener, and Emerging Growth reported earlier on International Frontier Resources Corporation (IFRTF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
International Frontier Resources Corporation has a demonstrated track record of advancing oil and gas projects. The OTCQB-listed Company, by way of its Mexican subsidiary, Petro Frontera S.A.P.I de CV and strategic joint ventures (JVs) is advancing the development of petroleum and natural gas assets in Mexico. International Frontier Resources is based in Calgary, Alberta.
International Frontier Resources (IFR) also has projects in the U.S. and Canada. This includes the State of Montana and the Northwest Territories. IFR created a JV company in 2015 - Tonalli Energia - together with Grupo Idesa, one of Mexico’s largest petrochemical companies. Grupo Idesa is a well-established Mexican petrochemical company.
Block 24 Tecolutla establishes IFR’s Mexican JV as one of the first operators’ in Mexico. In addition, it provides important insights into future rounds. Tecolutla is a very underdeveloped mature field with considerable upside potential. The Tecolutla Block is in the Tampico-Misantla Basin within the State of Veracruz.
The Tecolutla Field is 7.2 square kilometers. It contains an oil reservoir at 2,340 meters or around 7,700 feet. The Tecolutla Block is a 60-80 m gross pay carbonate reservoir on a structural high with proven oil production.
Tonalli has submitted the regulatory applications and documentation that will allow IFR to go ahead with the drilling permit and operations at Tecolutla. The expectation is that the existing wells at Tecolutla will exceed historic production numbers and peak initial production (IP) rates with the arrival of new recovering techniques, technology, and expertise to be undertaken by Tonalli.
This past November, International Frontier Resources Corporation (IFR) announced that Tonalli Energia, IFR’s JV with Mexican petrochemical leader Grupo IDESA, spudded the first conventional horizontal well, (TEC-11), at its onshore Tecolutla block. TEC-11 is the initial horizontal well in a potential multi-well plan to develop the northern extension of the Tecolutla field that has been identified on Tonalli’s interpretation of the 3D seismic.
Moreover, in December, IFR announced that Tonalli Energia reached total depth at its first conventional horizontal well, (TEC-11), on its onshore Tecolutla block. The TEC-11 field development horizontal well was drilled to a depth of 3283 meters (m) Measured Depth (MD). A total of roughly 670m of measured length of Cretaceous limestone was drilled before the total depth was reached. Oil shows were encountered during drilling.
Furthermore, Tonalli received its first payment from PEMEX for oil shipped from its Tecolutla field. Tonalli’s TEC-10 producing well averaged 156 barrels of oil per day in October and November at an approximate average crude sales price of USD$64.73 per barrel.
International Frontier Resources Corporation (IFRTF), closed Friday's trading session at $0.0277, up 53.8889%, on 40,000 volume with 5 trades. The average volume for the last 3 months is 46,376 and the stock's 52-week low/high is $0.0062/$0.026.
AEON Global Health Corp. (AGHC)
Amigo Bulls, Stock Target Advisor, Stockopedia, Investors Hangout, Penny Stock Hub, Stockwatch, Simply Wall St, Zacks, Stockhouse, InvestorsHub, YCharts, TradingView, The Street, Stockflare, and Dividend Investor reported on AEON Global Health Corp. (AGHC), and today we report on the Company, here at the QualityStocks Daily Newsletter.
AEON Global Health Corp., together with its subsidiaries, provides a variety of clinical laboratory testing services in the United States. The Company provides diagnostic services in Cancer Genomics, Toxicology, Pharmacogenomics, as well as Health Technology Applications. AEON formerly went by the name Authentidate Holding Corp. It changed its name to AEON Global Health Corp. in January 2018. OTCQB-listed, AEON Global Health has its corporate office in Gainesville, Georgia.
The Company is the fastest growing clinical lab and healthcare services organization in the United States. It is first in healthcare technology research and development (R&D) where its proprietary methodologies provide expedited and highly accurate urine and oral fluid (saliva) test results. AEON’s chief business focus is providing a “personalized medicine” approach to laboratory testing services. This is to provide customers with actionable medical information.
AEON is an innovator in the genomic testing area. The Company has an extensive menu of genetic tests and a pipeline of additional molecular-based tests in development. It provides post contract customer support services. The design of AEON’s Telehealth Solutions is to improve outcomes and reduce hospital readmission through helping clinicians closely monitor patients with chronic illnesses. These include CHF, COPD and Diabetes.
Concerning Toxicology Testing, AEON Global Health provides accurate and fast quantitative testing of drug metabolite levels in urine and oral ﬂuids. The Company’s testing covers more than 80 analytes and metabolites. Its HPLC-tandem mass spectrometry can analyze wider molecular weight and polarity ranges of analytes, providing better selectivity and sensitivity.
AEON Clinical Labs services include Cancer Genomics, Pharmacogenomics, Toxicology, and Women’s Health. Health Technologies services include Inscrybe®. This is a secure and simple interface. Inscrybe® enables physicians, nurses, hospital staff, and external care facilities or health insurers to send, receive, sign, and track healthcare records, supporting documents, patient discharge orders and referrals or lab results and images on the web or via electronic fax instead of transferring paper.
In May 2018, AEON Global Health announced it earned The Joint Commission’s Gold Seal of Approval® for Laboratory Services Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal of Approval is a symbol of quality, which reflects an organization’s commitment to providing safe and effective patient care.
AEON Global Health underwent a thorough onsite survey earlier in 2018. During the review, a Joint Commission expert surveyor evaluated compliance with laboratory standards related to a number of areas. This included document and process control, healthcare-associated conditions, risk reduction, as well as staff qualifications and competency. Additionally, the surveyor conducted onsite observations and interviews.
AEON Global Health Corp. (AGHC), closed Friday's trading session at $0.0128, up 56.0976%, on 117,123 volume with 7 trades. The average volume for the last 3 months is 26,152 and the stock's 52-week low/high is $0.082099996/$0.360000014.
CareView Communications, Inc. (CRVW)
Tiny Gems, MissionIR, Stockopedia, Stock Invest, Monster Stocks Pick, FeedBlitz, Real Pennies, PennyTrader Publisher, Wall Street Resources, Wallet Investor, Plunkett Research, TradingView, BabyBulls, Pink Investing, Stock Stars, and Capital Cube reported previously on CareView Communications, Inc. (CRVW), and today we report on the Company, here at the QualityStocks Daily Newsletter.
CareView Communications, Inc. is an Information Technology (IT) provider to the healthcare industry. CareView provides the next generation of patient care through its cutting-edge data and patient monitoring system. This system connects patients, families and healthcare professionals (the CareView System®). The CareView System can help a hospital reduce sitter costs, patient falls and injuries, manage patient flow, improve internal communications, and consolidate vendors. OTCQB-listed, CareView Communications has its corporate headquarters in Lewisville, Texas.
The CareView System is HIPAA (Health Insurance Portability and Accountability Act) -compliant and secure. The System does not record anything. Additionally, it can include consent processes and privacy options. Pertaining to hospital benefits, the CareView System enables patients to watch first-run movies and access high-speed internet. The result of this is increased patient satisfaction.
CareView Communications’ proprietary, high-speed data network system may be installed throughout a healthcare facility to provide the facility with recurring revenue and infrastructure for future applications. The CareView System allows for close observation of high-risk patients from numerous locations. The CareView Connect® mobile application provides patient monitoring and critical communication tools from an existing Wi-Fi Android or iOS device. The CareView System employs an infrared camera in patient rooms to deliver real-time visual monitoring 24/7.
CareView Communications offers its CareView Connect Senior Care Quality of Life System™. This is a unique family of products and services, which improve the quality of life and safety of seniors who reside in independent and assisted living facilities, or who live alone at home. The CareView Connect Senior Care Quality of Life System™ consists of a small emergency assist button or pendant, passive motion sensors, bed sensors, and event sensors. The CareView Connect System passively monitors a resident's daily activities.
Recently, CareView Communications announced the execution of a three-year group purchasing agreement with Pandion Optimization Alliance. Pandion is a 70-year old not-for-profit group purchasing organization dedicated to member hospitals, non-acute health-care related facilities and related industries. Pandion GPO has thousands of members covering 50 states. Pandion GPO provides an assortment of supply chain services and solutions including group purchasing and supply chain consulting to help lessen costs, streamline operations and improve performance of its members.
CareView Communications, Inc. (CRVW), closed Friday's trading session at $0.278, up 54.4444%, on 6,671 volume with 6 trades. The average volume for the last 3 months is 2,101 and the stock's 52-week low/high is $0.00019/$0.694000005.
Oncolix, Inc. (ONCX)
NetworkNewsWire, Stock News Now, Stockhouse, Penny Stock Hub, SmallCapVoice, Stockwatch, OTC Markets, Marketwired, The Street, Dividend Investor, Investopedia, Barchart, Stockopedia, and InvestorsHub reported earlier on Oncolix, Inc. (ONCX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
RedHawk Holdings Corp. is a diversified holding company listed on the OTC Markets. The Company, via its subsidiaries, engages in the sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services. RedHawk Holdings was formerly Independence Energy Corp. RedHawk’s subsidiaries are RedHawk Medical, EcoGen Europe, RedHawk Energy Corp., and RedHawk Land & Hospitality. RedHawk Holdings is based in Louisiana.
RedHawk Energy holds the exclusive U.S. manufacturing and distribution rights for the Centri Controlled Entry System. This System is a unique, closed cabinet, nominal dose transmission full body x-ray scanner.
Through its RedHawk Medical Products business unit, RedHawk Holdings sells WoundClot Surgical - Advanced Bleeding Control; the Sharps and Needle Destruction Device (SANDD™); the Carotid Artery Digital Non-Contact Thermometer, and Zonis®.
RedHawk Medical Products UK Limited is a specialist medical device company. It delivers innovative product solutions to healthcare markets in the United Kingdom (UK), Europe and the Middle East.
EcoGen Europe’s dedication is to healthcare and the NHS. Its commitment is to securing savings across the drug budget in primary care. This is while providing innovation to drive patient care in the acute setting. Last month, RedHawk Holdings announced that it recently completed its financial and legal due diligence and upon execution of final agreements, it will increase its ownership interest in EcoGen Europe to 75 percent.
RedHawk’s financial services revenue is from brokerage services earned in association with debt placement services and investments in oil and gas exploration and production. The Company’s real estate leasing revenues come from varied commercial properties under long-term lease. Moreover, its real estate investment unit holds limited liability company interest in different commercial restoration projects in Hawaii.
EcoGen Europe has signed an exclusive agreement to license and supply a new non-patent infringing generic spray formulation of Sildenafil Citrate in the UK. EcoGen will market the new spray under the brand name Azulvig. EcoGen expects to start marketing Azulvig after receipt of final UK regulatory approval.
RedHawk Holdings has acquired a stake in Tigress Energy Partners. RedHawk agreed to acquire up to a 25 percent interest in Marlin USA Energy Partners, LLC, the minority owner of Tigress Energy Partners, LLC (TEP). The majority ownership of TEP is held by Tigress Holdings, LLC, a limited liability company majority-owned by Cynthia DiBartolo, Chief Executive Officer of Tigress Financial Partners LLC (TFP).
RedHawk Holdings has also completed the re-engineering of its Sharps and Needle Destruction Device (SANDD). It received pre-market clearance from the U.S. Food and Drug Administration (FDA) for the sale of SANDD in the U.S. RedHawk Medical Products acquired the tangible and intangible property rights to SANDD (formerly known as the Disintegrator™ Insulin Needle Destruction Unit) in December 2015.
In early August, RedHawk Holdings announced that its wholly-owned real estate subsidiary, RedHawk Land & Hospitality LLC, entered into new agreements for the lease of its two commercial properties in Lafayette, Louisiana. The Company said it entered into a new triple-net lease agreement with the Louisiana 3rd Circuit Court of Appeal to renew and extend the present lease term to December 31, 2022. The new lease agreement was effective August 1, 2017 and included certain rate increases.
Oncolix, Inc. (ONCX), closed Friday's trading session at $0.0001, up 9,900.00%, on 26,000 volume with 2 trades. The average volume for the last 3 months is 2,316,613 and the stock's 52-week low/high is $0.00001/$0.024.
The QualityStocks Company Corner
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- SinglePoint, Inc. (SING)
- Sugarmade, Inc. (SGMD)
- Hemptown USA
- Trxade Group Inc. (TRXD)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Earth Science Tech, Inc. (ETST)
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
- Grapefruit Boulevard Investments Inc. (IGNG)
- Golden Developing Solutions, Inc. (DVLP)
- Marijuana Company of America Inc. (MCOA)
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality interactive entertainment games and toys in China, announces the pricing of its underwritten initial public offering (“IPO”) of 2,000,000 ordinary shares at a public offering price of $4 per share, before underwriting discounts and commissions. Also today, NetworkNewsWire released a report on the company detailing how BHAT is “One to Watch.”
Blue Hat Interactive Entertainment Technology (BHAT) is a cutting-edge creator, developer and operator of popular augmented reality (“AR”) interactive smart toys and educational games in China. Blue Hat’s mobile-connected entertainment platform connects physical items to mobile devices through wireless technologies, creating a unique interactive user experience in various mobile games, interactive educational materials and toys with mobile game features.
Blue Hat designs original toys and games that utilize augmented reality technology, motion capture technology, image recognition technology, voice control, light sense technology, infrared, levitation induction, and other trending scientific technologies to transverse the virtual with reality. Blue Hat creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. This combination provides users with a more natural form of human computer interaction, enhances a user’s perception of reality, and delivers a more immersive entertainment experience.
Founded in 2010, Blue Hat’s proprietary technology, product research and development, marketing channels and brand operation are the cornerstones of the business. Blue Hat focuses on the combination of “online” and “offline” activity and the interaction between “entertainment” and “product” to create a high-tech entertainment platform combining mobile games and AR. With the help of computer graphics, motion capture technology, image recognition technology and visualization technologies, Blue Hat accurately “places” virtual objects into the physical world, creating a new and stimulating visual environment for users.
Blue Hat recently displayed a variety of its sci-tech products at the Guangzhou International Toy Exhibition in China including AR Racer, Elastic Bubbles, AR Space Track, AR Alloy Toy Car, AR Need a Spanking, 5D Animated Magic Aquarium, Bug Travelers, AR Picture Book and other interactive games and smart toys.
The company has multiple products in development including new generations of four primary product lines and two new product lines.
Patents and Copyrights
Blue Hat’s advanced AR technology in interactive entertainment is protected by 178 authorized patents with 44 patents in various stages of the application process.
Another 14 applications for Patent Cooperation Treaty, or PCT, have been filed for international patents. As of March 31, 2019, the company owns 645 copyrights for artwork, 71 registered trademarks and 27 software copyrights.
Sales and Marketing
There has been rapid growth in the toys and games industry in China over the last several years. Total retail sales of toys and games in China soared from RMB 111.8 billion in 2012 to RMB 276.5 billion in 2017 with an average annual growth rate of 19.9% in 2017. Blue Hat believes the company is well positioned with little competition as the toy industry rapidly shifts toward intelligent and interactive toys and games. Retail sales of electronic toys grew at 24% annually in 2017 while that of traditional toys grew at 7%.
In addition to a powerful ecommerce presence, Blue Hat has long-term relationships with partnered distributors that place the company’s AR interactive entertainment products into well-known international retail chains and retail outlets. Blue Hat’s integrated online and offline sales channels include e-commerce giants such as Amazon and Alibaba, retail chain stores and the company’s physical experience store located in Xiamen, China. Blue Hat plans to open or franchise approximately 100 additional stores in China by 2021.
Blue Hat’s community-based platform offers users a highly engaged and interactive community with online communication forums and offline social activities. The company advocates a new model of “teaching through lively activities” and combines AR technology with education, integrating its products into situational teaching, roleplaying and man-machine interaction. This novel educational experience helps realize optimal transformation of information, creating a knowledge and enhancing cognition.
Director and CEO Xiaodong (Sean) Chen has over 20 years of experience creating, developing and producing toys and games related products. Chen earned his EMBA from Renmin University of China and has been chairman of the board of directors and general manager of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.
CFO and Director Caifan, who has over 20 years of financial accounting and taxation experience, earned a degree in finance from Hunan University of Finance and Economics. He has served as director, deputy general manager and financial controller of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.
Jianyong Cai, chief technology officer and director, has over 35 years of experience in data communication principles, communication network foundation, software engineering, communication network theory and technology and computer network architecture. He holds degrees in data communication principles, communication network foundation and software engineering from University of Science and Technology of China. He has been director, deputy general manager and chief engineer of Fujian Blue Hat Interactive Entertainment Technology Ltd. since January 2010.
Blue Hat Interactive Entertainment Technology (BHAT), closed Friday's trading session at $4.58, up 14.50%, on 1,743,807 volume with 6,419 trades. The stock's 52-week low/high is $4.1600/$6.2500.
- Blue Hat Interactive Entertainment Technology Announces Pricing of IPO and Increases Offering Size
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) is “One to Watch”
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (NASDAQ Global Select; TSX-V: OGI) the parent company of Organigram Inc. (collectively the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that it has entered into an advance payment and purchase agreement (the “Payment Agreement”) with 703454 N.B. Inc. (carrying on business as 1812 Hemp) (“1812 Hemp”) under which the Company will pre-fund hemp purchases to receive access to as much as 60,000 kilograms of dried hemp flower to be harvested in calendar 2019 for extraction into cannabidiol (“CBD”) isolate. Also today, NetworkNewsWire released a report on the company detailing how OGI has developed a proprietary nano-emulsification technology. This new unique, fast-acting formulation will allow for the production of both powdered and liquid cannabinoid products. The development comes in the context of the much-anticipated legalization of adult recreational-use cannabis edibles in Canada and the ensuing boost in demand, as the company noted in a news release (http://nnw.fm/eT5Y0). Additionally, the company was highlighted in the Investor Ideas Potcast, from Investorideas.com. Listen to the podcast: http://ibn.fm/Oimg6 .
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Friday's trading session at $5.90, up 1.2007%, on 643,231 volume with 2,557 trades. The average volume for the last 3 months is 1,108,069 and the stock's 52-week low/high is $0.697000026/$3.16000008.
- Organigram Signs New Agreement for Access to 60,000kg of CBD-rich Hemp
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Announces Proprietary Nano-Emulsion Technology for Rapid-Onset of Cannabinoid Effects
- Investor Ideas Potcasts, Cannabis News and Stocks on the Move July 26th
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a manufacturer and marketer of cannabis food products, has rebranded its line of low-dosage, cannabis-infused edibles. The goal behind the new look is to ensure clarity and differentiation to its Uplift, Balance and Unwind lines for consumers (http://nnw.fm/9LFdk).
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Friday's trading session at $2.87, off by 0.966184%, on 69,056 volume with 64 trades. The average volume for the last 3 months is 56,978 and the stock's 52-week low/high is $0.850000023/$2.03999996.
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Debuts New Look for Cannabis Line
- PLUS Products Kicks off Advertising Campaign Across California
- Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Committed to Product Consistency, Quality for Cannabis Edibles Brand
SinglePoint, Inc. (SING)
Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally-syndicated program covers money-focused topics, featuring various companies and in-depth CEO and executive interviews that offer insights into operations and future outlooks. On this week’s program, SinglePoint CEO Greg Lambrecht provided updates on the company’s acquisition sales success, as well as its CBD business and merchant services progress. To view the full press release, visit: http://nnw.fm/A3Hkl.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Friday's trading session at $0.014138, up 0.985714%, on 2,141,282 volume with 101 trades. The average volume for the last 3 months is 56,978 and the stock's 52-week low/high is $0.300999999/$2.45000004.
- SinglePoint, Inc. (SING) CEO Discusses Acquisition Sales Success, CBD Business and Merchant Services Progress on MoneyTV with Donald Baillargeon
- SinglePoint, Inc. (SING) Subsidiary Adds Alternative Energy Financing Solution
- SinglePoint Inc. (SING) Focuses on New Technologies, Offers Diverse Opportunities
Sugarmade, Inc. (SGMD)
Sugarmade, Inc. (OTCQB: SGMD), a major supplier to the growing hydroponic cultivation and hemp sectors, today provides an update to its investors relative to two important topics – Status of its investments in Kentucky-based hemp cultivator, Hempistry, Inc. and on the status of its pending acquisition of hydronic cultivation supplier, BZRTH, Inc. ("BZRTH").
Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6
Sugarmade, Inc. (SGMD), closed Friday's trading session at $0.5375, up 1.4151%, on 158,093 volume with 83 trades. The average volume for the last 3 months is 191,679 and the stock's 52-week low/high is $0.160099998/$0.920000016.
- Sugarmade Announces Initial Investment in Hempistry and Completion of BZRTH Audit
- 420 with CNW – Second Marijuana Home Delivery Lawsuit Filed in California
- Sugarmade Inc. (SGMD) Tapping into Growing Hydroponic Supply Demand
The QualityStocks Daily Newsletter would like to spotlight Hemptown USA.
Hemptown USA recently announced the acquisition of assets that consist of the FDA-licensed, cGMP-certified operating nutraceutical business of the Kirkman Group (http://ibn.fm/GaNUI). The Kirkman Group’s fully operational 25,000-square-foot nutraceutical facility holds equipment and formulations intended to facilitate precision dosage of cannabidiol (“CBD”) and cannabigerol (“CBG”) product formulations, including tinctures, gel caps, topical products and edibles. An article discussing the company reads, “In the spring of 2019, Hemptown USA acquired 4.5 million rare hemp seeds. To view the full article, visit http://ibn.fm/oL9No.
Hemptown USA, headquartered in Central Point, Oregon, is a proven grower of full-spectrum hemp biomass grown using premium seed genetics that contain less than 0.3% THC and exceptionally high cannabinoid (CBD) content of up to 20%. The company's "soil to oil" methodology combines seasoned professionals working in hand-picked agricultural microclimates located in Oregon's famed Emerald Triangle, Kentucky and Colorado.
Hemptown has exclusive rights to 1 million rare CBG (cannabigerol) seeds genetically programmed to yield from 15% to 20% full-spectrum non-intoxicating cannabinoids. As a result of a long-standing relationship with the one of the world's most respected cannabis breeding companies – Oregon CBD Seeds – Hemptown is positioned to be a leading CBG producer in the U.S. in 2019 and beyond.
In 2018 Hemptown's harvest from its Oregon hemp farm was 150,000 pounds of full-spectrum biomass with CBD content hovering around 17%. 2018 harvest revenue expected to range from $8.1 million to $12.6 million. The company is scaling up operations in 2019 to meet market demands and projects it will reap over 1,000,000 pounds. By 2020, Hemptown projects potential revenues in the $100 million to $200 million range are possible once additional farming operations are at full strength.
By 2020, Hemptown anticipates it will have more than 3,000 acres in several states dedicated to hemp farming. Expansion plans include increasing in-house extraction capabilities to boost profit margins by providing additional CBD and CBG isolates and distillation services. Development of business-to-business channels as well as new products and formulations for the direct-to-consumer market, along with several strategic acquisitions, are also key to Hemptown's growth strategy.
Hemptown plans to expand distribution and growing operations globally through strategic partnerships and development of contracts with leading Fortune 500 brands in European markets. The company intends to grow its IP portfolio by developing a proprietary water-soluble cannabinoid delivery system. Not to be confused with water-compatibility, water-soluble cannabinoids combine seamlessly with other liquids, have a superior shelf life, and deliver dramatically increased efficacy to the consumer.
Hemptown's first in-house branded product line combines the inspiring strength found in the unbridled nature that surrounds the company's original hemp farm in the Siskiyou Klamath region of Oregon. Sisku is set to redefine the cannabinoid packaged goods space with an elegant look, clean feel and potent, reliable efficacy.
Custom product lines can also be created for any product manufacturer as Hemptown brings GMP and ISO accredited processing facilities online in 2019. Together with Oregon CBD Seeds and Hemptown's product sciences team, Hemptown will be able to create custom, proprietary full-spectrum CBD and CBG oils and pure isolates.
Company Chairman Rod Wolterman founded Hemptown's Oregon operations in 2016. He has extensive experience in the cannabis sector having been active within the space since 1998. Wolterman has also acted as a private equity investor in numerous medical marijuana dispensaries and cultivation operations in southern California.
CEO John Cummings has over 20 years of experience in finance, marketing, sales and project management. He led the compliance and special projects efforts for Kings Garden, one of the largest vertically integrated operators in California. Cummings also spent a year in Europe launching the continent's first GMP and ISO-accredited cultivation and manufacturing facility.
Dr. Gordon Chiu is chief science officer for Hemptown USA. He has more than 15 years of combined domestic and international experience in biomedical, chemical, cosmetic, medical and technology industries. A graduate of Rensselaer Polytechnic Institute with a master's degree from Seton Hall University, Chiu is leading Hemptown's cannabinoid research team and is responsible for filing IP patents, specifically in the areas of water-solubility, bioavailability and peptide sequencing.
- Hemptown USA Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- Hemptown USA Acquires Leading Nutraceutical Manufacturing Facility
- Keeping Hemp Production Costs Low through Technology: How Hemptown USA is Changing the Lucrative Market
Trxade Group Inc. (TRXD)
Integrated pharmaceutical logistical services company Trxade Group (OTCQB: TRXD) hosts a supplier-to-pharmacy (“S2P”) pharmaceuticals trading platform that is helping pharmacists protect their profit margins by evading negative reimbursement costs. To view the full article, visit: http://nnw.fm/Ax8gD.
Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.
Trxade will leverage and scale its fully integrated model to execute the following growth strategies:
- Increase share of pharmacist drug purchasing
- Additional SKUs and expand product breath
- Partner with Specialty and International Mfg.
- Expand mail order licenses to all 50 states
- Scale Delivmeds for consumer delivery nationwide
- Integration with telemedicine
- M&A Opportunities within drug value chain
Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.
The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.
Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.
Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!
Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.
The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.
Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.
These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.
Health Care Market
The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.
Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.
Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.
TRxADE's programs include:
- TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
- RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
- Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.
Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.
Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.
Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.
Trxade Group Inc. (TRXD), closed Friday's trading session at $0.539, even for the day, on 10 volume with 1 trade. The average volume for the last 3 months is 2,415 and the stock's 52-week low/high is $0.009999999/$0.041000001.
- Trxade Group Inc.’s (TRXD) Web Platform Protects Profit Margins, Cuts Negative Reimbursement Costs
- Trxade Group Inc. (TRXD) Building Reputation of Transparency in Effort to Improve on Pharmaceutical Supply Chain Concerns
- Trxade Group Inc.’s (TRXD) Proprietary Web-Based TRxADE Platform Targets Nation’s Independent Pharmacy Marketplace
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) was featured today in the 420 with CNW by CannabisNewsWire. A coalition of more than a hundred cannabis companies and industry groups has sent a letter to Congress urging lawmakers to include social equity in any legislation that is proposed as a way of ending marijuana prohibition. The letter, sent on Thursday last week, asserts that the work of Congress will be incomplete if they only stopped at legalizing marijuana without going further to address issues of social equity.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Friday's trading session at $1.12, up 1.7719%, on 301,228 volume with 376 trades. The average volume for the last 3 months is 316,200 and the stock's 52-week low/high is $1.51999998/$4.0999999.
- 420 with CNW – More than 100 Cannabis Businesses Ask Congress to Consider Social Equity During Legalization
- Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Expands Executive Team; Appoints New Chief Information Officer and VP of Talent
- Supreme Cannabis Appoints New Chief Information Officer and VP of Talent
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, remains dedicated to maintaining its high standards in the midst of a growing cannabis supply gap. To view the full article, visit: http://nnw.fm/sKjH2.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at firstname.lastname@example.org
The Green Organic Dutchman (OTC: TGODF), closed Friday's trading session at $2.09, off by 2.3364%, on 946,664 volume with 1,311 trades. The average volume for the last 3 months is 513,323 and the stock's 52-week low/high is $7.00/$11.50.
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Upholds Commitment to Quality amid CBD Shortage
- Strong Demand for CBD Edibles to Create a $4.1 Billion Market by 2022
- 420 with CNW – Second Marijuana Home Delivery Lawsuit Filed in California
Earth Science Tech, Inc. (ETST)
Earth Science Tech (OTCQB: ETST), a Florida-based biotechnology company, recently reported a 66.4% increase in revenue during the 12 months ended March 31 compared to the same period of the previous year (http://nnw.fm/sXqz2). To view the full article, visit: http://nnw.fm/xfc7M.
Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.
Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:
- Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
- Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
- KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.
In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.
The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.
Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.
Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.
The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.
Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.
Earth Science Tech, Inc. (ETST), closed Friday's trading session at $0.76, even for the day, on 19,817 volume with 18 trades. The average volume for the last 3 months is 54,996 and the stock's 52-week low/high is $3.56999993/$16.25.
- Earth Science Tech Inc. (ETST) Attributes Increases in Distribution, Demand for Upsurge in Revenues
- Earth Science Tech Inc. (ETST) Strengthens Foothold in Global CBD Arena
- Earth Science Tech Inc. (ETST) Stock Evaluated by InvestorPlace Analyst
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) was featured today in the 420 with CNW by CannabisNewsWire. A recent study shows that cannabis extracts can impair the survival of some types of cancer cells and also inhibit their spread. However, the effects of the cannabis extracts vary according to the chemical profile of the extracts used, the researchers discovered.
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.
Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.
Gathered within the growing family of Wildflower brands are the following entities:
- Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
- King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
- Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.
Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.
Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.
In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.
Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.
William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.
CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.
Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.
Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.
Wildflower Brands Inc. (WLDFF), closed Friday's trading session at $0.3893, off by 0.230651%, on 6,204 volume with 6 trades. The average volume for the last 3 months is 14,125 and the stock's 52-week low/high is $0.76999998/$5.25.
- 420 with CNW – Study Looks at How Marijuana Extracts Can Kill Cancer Cells
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Doubles Retail Reach through Dillard’s Launch
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Focuses on Expanding Suite of CBD, Hemp-Derived Products
Grapefruit Boulevard Investments Inc. (IGNG)
California-based Grapefruit Boulevard Investments, a wholly owned subsidiary of Imaging3 (OTCQB: IGNG), holds licenses initially issued by the state of California in January 2018 to manufacture and distribute cannabis products. To view the full article, visit: http://nnw.fm/4uaUw.
Grapefruit Boulevard Investments Inc., a California corporation (“Grapefruit”), as of May 31, 2019, is a wholly owned subsidiary of Imaging3 Inc. (OTC: IGNG), a Delaware corporation whose shares of $.001 par value common stock are publicly traded on the OTCMarkets OTCQB Market under the symbol “IGNG.” IGNG is subject to the reporting requirements of the Securities Exchange Act of 1934 and files annual and quarterly reports pursuant thereto. Grapefruit holds licenses originally issued by the State of California in January 2018 to both manufacture and distribute cannabis products. Grapefruit’s management now owns a controlling interest in IGNG which now owns 100% of Grapefruit’s outstanding shares. As a result, IGNG’s financial reports will consolidate both IGNG’s and Grapefruit’s balance sheet, statement of operation and statement of cash flows and IGNG and Grapefruit will be operated as a single company. IGNG intends to change its name to Grapefruit and to obtain a more appropriate trading symbol as soon as possible. Hereinafter the combined companies will be referred to as “Grapefruit” or the “Company.”
Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds licenses to both manufacture and distribute cannabis products which were originally issued in January 2018 and is fully compliant with all applicable laws and regulations to operate its cannabis manufacturing and distribution businesses.
The company is well-focused on sourcing only the “best of the best” raw cannabis materials to create the highest quality, most-trusted and consistent recreational and medical cannabis products for its customers. Grapefruit is committed to ensuring class-leading quality by rigorously testing the purity and potency of its raw materials throughout the manufacturing process and distribution chain.
Grapefruit owns and operates its fully licensed and compliant ethanol extraction laboratory located in the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. The company’s extraction lab produces high quality, cannabis-derived distillate, also known as “honey oil,” from cannabis flower and “trim.” THC honey oil is one of base cannabis commodities which serves as the active ingredient in everything from infused edibles and tinctures/creams to the cartridges used in vapes and e-cigarettes. Honey oil often sells on the wholesale marketplace for thousands of dollars per liter, with pricing being dependent on quantity purchased, as well as other market factors such as the availability and cost of the underlying flowers and/or trim.
Grapefruit began its extraction operations in May 2019. Plans are in place to expand its honey oil production through the purchase of additional distillation equipment, which is expected to significantly increase the company’s production capacity by the fourth quarter of 2019. Grapefruit’s extraction lab is fully scalable and expansion will be built-out on a two-acre lot owned by Grapefruit at the Coachillin’ site adjacent to its current manufacturing and distribution operation.
Grapefruit selected the City of Desert Hot Springs for its cannabis extraction laboratory, because the city has created a friendly business environment for cannabis-based manufacturers, including incentives like the absence of taxes on cannabis oil production revenues. This affords Grapefruit a fundamental competitive market advantage over other Honey Oil producers.
The California cannabis regulatory scheme is unique in that it requires all cultivators (cannabis farms) and manufacturers (whether producing oils/distillates, infused edibles, tinctures creams or other cannabis products) to sell their products into the legal cannabis wholesale and retail markets exclusively through licensed distributors such as Grapefruit. Grapefruit initially obtained its California recreational and medicinal cannabis distribution license Jan. 4, 2018. In May 2019, Grapefruit was granted its provisional distribution license which is renewable annually, thereby cementing the regulatory foundation necessary to rapidly expand its distribution business.
Grapefruit’s distribution license affords it a twofold strategic advantage: first, to market and sell its own cannabis product lines to retailers throughout California; and second, to buy and resell bulk cannabis flowers and trim as well as all other legal cannabis products to properly licensed distributors and/or retailers throughout California.
The Coachillin’ Canna-Business Park, home to Grapefruit’s current operating facilities and adjacent two-acre parcel of land, is a 160-acre, self-contained legally mapped compound providing the Company with a fully permitted and serviced physical plant from which Grapefruit intends to establish a leading position in the booming California cannabis sector. The parcel was purchased by the Company prior to the Park’s full development, and the value of the land the Company owns has conservatively since doubled in value to over $2 million. Additional long-term benefits of the Coachillin’ compound include agricultural rates for power, which are currently $0.09 per kilowatt hour; the Park’s deep-water well that fully satisfies its need for water; and security expenses shared by all resident businesses. The Coachillin’ Park’s promoters also plan to position the Park, located only 10 miles north of rapidly growing uptown Palm Springs and less than 15 miles from the site of the Coachella and Stagecoach music festivals as a must-see canna-tourism destination.
Grapefruit’s ultimate goal is to become a vertically integrated, seed-to-sale cannabis and CBD product company serving the California market. Moreover, it plans to roll-out its product lines in other states, such as Nevada, Illinois, Oregon, Colorado and Washington. Grapefruit has plans to build a large, all-inclusive facility that will house a 50,000-square-foot-plus indoor grow canopy, a large extraction laboratory designed to extract both THC and CBD cannabinoids via non-volatile (ethanol) and volatile (butane) processes, a manufacturing space to produce Grapefruit’s vape lines and CBD products, an FDA-certified kitchen for the production of Grapefruit edibles and a distribution facility to sell all products into the entire cannabis market. The indoor grow canopy operation will be outfitted and operated to produce ultra-high-quality flowers and buds, some of which, along with the high-quality trim resulting from cleaning and maintaining the grow, will provide biomass necessary to feed the company’s extraction laboratory. Fueled by this hand cultivated biomass, Grapefruit’s lab will continuously produce pesticide and heavy metal-free world class honey oil to both serve as the active ingredient in all of Grapefruit’s branded and unbranded products and meet the projected ever-growing demand for high quality honey oil in the California market.
Grapefruit’s motto – A High You Can Trust – embodies its philosophy and ethos, reminding consumers of the company’s commitment to manufacturing, procuring and distributing only the highest quality all-natural cannabis flower, concentrates and related products that are free from pesticides, heavy metals and bacteria. Grapefruit will target its products to all recreational cannabis enthusiasts’ as continuous, consistent cannabis products. By relentlessly adhering to these policies Grapefruit intends to become the Titleist of the Cannabis industry, known for unwavering quality and consistency.
Grapefruit is managed by a team of experts possessing the experience, skill and resources required to succeed in the competitive cannabis marketplace. Founded by brothers Bradley Yourist, CEO, and Daniel Yourist, COO, Grapefruit has expanded to become a group of industry professionals sharing a passion for all things cannabis. Both the CEO & COO are attorneys licensed to practice law the State of California who possess expert cannabis licensing and regulatory expertise and experience, which will allow Grapefruit to deftly navigate the ever changing California regulatory landscape and apply for new cannabis licenses at reduced costs when necessary, rather than having to acquire licenses that are often overvalued and/or pay outside counsel to handle such matters.
Grapefruit also has its own line of cannabis-infused concentrates and edibles. Among the brands now in stores or soon to be launched are:
- Rainbow Dreams is a new lifestyle brand designed specifically for the recreational cannabis marketplace. The Rainbow Dreams brand captures the anything goes party vibe of the 1970s by offering an array of cannabis products, such as a line of vape carts with unique cannabis strains combined with all-natural flavors for a superior no-burn experience. Rainbow Dreams fills an important niche in the marketplace as a top shelf quality product line that is competitively priced.
- Sugar Stoned, which Grapefruit acquired in the winter of 2018, has always been a popular cannabis edibles brand which terminated operations when recreational cannabis became legal and required a license in California. Grapefruit purchased the Sugar Stoned brand in 2019 and it is now a Grapefruit portfolio brand consisting of a premium quality cannabis-infused gummy line with eight different flavors: blue raspberry, cherry, grape, peach, pineapple, sour apple, strawberry and watermelon. Grapefruit intends to expand the brand in the near future through the release of a variety of infused cookies.
Grapefruit Boulevard Investments Inc. (IGNG), closed Friday's trading session at $0.07955, off by 7.7146%, on 17,850 volume with 9 trades. The average volume for the last 3 months is 184,761 and the stock's 52-week low/high is $0.189099997/$1.875.
- NetworkNewsBreaks – Why Grapefruit Boulevard Investments Inc. (IGNG) Is ‘One to Watch’
- Grapefruit Boulevard Investments Inc. (IGNG) to Acquire Premier Retail Dispensaries in Expanding California Cannabis Marketplace
- Coverage Initiated for Grapefruit Boulevard Investments via NetworkNewsWire
Golden Developing Solutions, Inc. (DVLP)
Golden Developing Solutions Inc. (OTC: DVLP) reported sales of $1,965,641 for Q2 2019, ended June 30. DVLP is an early-stage emerging company offering business services and/or products supporting the cannabis industry. The company’s portfolio includes several fully owned ancillary technology, CBD and cannabis businesses (http://nnw.fm/9OBs4). Also today, NetworkNewsWire released a report on the company detailing how DVLP recently announced the completion of phase one of its strategic vertical integration (http://nnw.fm/t1Y0g). To view the full article, visit: http://nnw.fm/6qzKA.
Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.
Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.
DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.
WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.
“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”
The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.
“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”
Golden Developing Solutions, Inc. (DVLP), closed Friday's trading session at $0.0108, off by 6.087%, on 387,082 volume with 19 trades. The average volume for the last 3 months is 1,517,310 and the stock's 52-week low/high is $0.026/$0.119999997.
- Golden Developing Solutions Inc. (DVLP) Announces Record Preliminary Revenues for Q2 2019
- Golden Developing Solutions Inc. (DVLP) Implements Vertical Integration Approach
- Golden Developing Solutions Inc. (DVLP) Achieves Fully Reporting Status, Reports Revenue Growth
Marijuana Company of America Inc. (MCOA)
Marijuana Company of America Inc. (OTCQB: MCOA) continues to build steam in its efforts to light up the enormous California cannabis market, announcing an expanded hempSMART product line and the prelaunch of signups for its premier cannabis distribution service and home cannabis business fostering strategy.
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed Friday's trading session at $0.006186, off by 1.8095%, on 9,264,256 volume with 172 trades. The average volume for the last 3 months is 8,635,438 and the stock's 52-week low/high is $0.032000001/$2.5999999.
- Marijuana Company of America Inc. (MCOA) Continues to Build Steam in California’s Cannabis Marketplace
- Marijuana Company of America Announces Prelaunch of Premier Cannabis Delivery Service
- Total Impact of Cannabis Market Projected to Reach $48 Billion In 2019
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) 420 with CNW – Senate Could Hold Hearings on Cannabis Banking Later this Month
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Flagship PharmHouse JV Licensed By Health Canada
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Completes Investment in New Jersey Cannabis Applicant - ACS
- ChineseInvestors.com (CIIX) Provides Premier Market Data Via Unique Website
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green Holdings Inc. (CSE: CVGR) Reports Debt Settlements, Further Transactions
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Reports Strong Attendance at Signature Fun Runs
- Earth Science Tech, Inc. (ETST) Strengthens Foothold in Global CBD Arena
- Endonovo Therapeutics (OTCQB: ENDV) SofPulse Safely Reduces Pain, Swelling
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) QuadSight(TM) Prototype Ordered by American Subsidiary of Leading Global Supplier
- Genprex Inc. (NASDAQ: GNPX) Provides Update on Lead Drug Candidate for Treatment of Non-Small Cell Lung Cancer
- Geyser Brands Inc. (TSX.V: GYSR) Appoints Seasoned Life Sciences Executive to Board of Directors
- Golden Developing Solutions, Inc. (DVLP) Achieves Fully Reporting Status, Reports Revenue Growth
- Grapefruit Boulevard Investments Inc. (IGNG) to Acquire Premier Retail Dispensaries in Expanding California Cannabis Marketplace
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Announces Bought Deal Public Offering of Units
- Green Hygienics Holdings Inc. (GRYN) Secures License for Processing Hemp in the State of North Carolina
- Hemptown USA - Acquires Leading Nutraceutical Manufacturing Facility
- INmune Bio, Inc. (NASDAQ: INMB) Co-Founder and CEO Presents at 17th Annual Congress of International Drug Discovery Science & Technology 2019
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Completes Acquisition of Zoots - Premium Cannabis-Infused Edibles and Infused Products
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Agreement Increases Reach of Ingested Cannabis Absorption Technology
- Marijuana Company of America Inc. (MCOA) Announces Prelaunch of Premier Cannabis Delivery Service
- MustGrow Biologics Corp (CSE: MGRO) Counters Use of Controversial Pesticides with Natural, Effective Biopesticides and Biofertilizers
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) Acquires 49% Interest in Budding Cannabis Industry Disruptor
- Nightfood, Inc. (OTCQB: NGTF) to Present at VirtualInvestorConferences.com on August 1, 2019
- Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Analysts Projected Numbers Differ on Revenue Potentials but Agree on Continued Growth in CBD Products Market
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) President Issues Letter to Shareholders
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Achieves Key Milestone of Form 10 Registration Statement Effectiveness
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Kicks off Advertising Campaign Across California
- Pressure BioSciences Inc. (PBIO) Announces First Sale of the BaroShear K45, A Revolutionary Water-Soluble CBD Manufacturing System
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Holds Favorable Position as Rising EV Market Boosts Lithium Demand Worldwide
- Sharing Services Global Corporation (SHRG) Capitalizing on New Direct-Selling Opportunities Driven by Changing Retail Industry
- SinglePoint, Inc. (SING) Subsidiary Adds Alternative Energy Financing Solution
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Launches Uniden UV350 Desktop Dispatch Unit for Instant Communication to In-Vehicle and Mobile Enterprise Workforce
- Spectrum Global Solutions, Inc. (SGSI) Evolving with Acquisition of German Energy Infrastructure Tech Company
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Ideally Positioned in High-Growth Market
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Breaks Ground for Its Direct Lithium Extraction Demonstration Plant
- Sugarmade, Inc. (SGMD) 420 with CNW – Second Marijuana Home Delivery Lawsuit Filed in California
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Expands Executive Team; Appoints New Chief Information Officer and VP of Talent
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Strong Demand for CBD Edibles to Create a $4.1 Billion Market by 2022
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Continues Testing of TherOZap(TM) Technology Against the Zika Virus
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) 420 with CNW – Thousands Submit Comments Urging FDA to Allow CBD in Supplements and Foods
- Trxade Group Inc. (TRXD) Proprietary Web-Based TRxADE Platform Targets Nation’s Independent Pharmacy Marketplace
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) 420 with CNW – Thousands Submit Comments Urging FDA to Allow CBD in Supplements and Foods
- VPR Brands, LP (VPRB) Featured in Exclusive NetworkNewsWire Broadcast
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Doubles Retail Reach through Dillard’s Launch
- Willow Biosciences Inc. (CSE: WLLW) 420 with CNW – Michigan Caregivers Grow More than a Million Marijuana Plants
- Youngevity International, Inc. (NASDAQ: YGYI) 420 with CNW – Michigan Caregivers Grow More than a Million Marijuana Plants
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.